161 related articles for article (PubMed ID: 9780089)
1. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
3. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
[TBL] [Abstract][Full Text] [Related]
4. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
[TBL] [Abstract][Full Text] [Related]
5. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
[TBL] [Abstract][Full Text] [Related]
6. Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.
Mosconi L; Sorbi S; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Herholz K; Pupi A
Psychiatry Res; 2004 Feb; 130(2):141-51. PubMed ID: 15033184
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
Hirono N; Mori E; Yasuda M; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):362-7. PubMed ID: 9876966
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
Ossenkoppele R; van der Flier WM; Zwan MD; Adriaanse SF; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van Berckel BN
Neurology; 2013 Jan; 80(4):359-65. PubMed ID: 23255822
[TBL] [Abstract][Full Text] [Related]
9. Cerebral glucose metabolism in patients with AD and different APOE genotypes.
Drzezga A; Riemenschneider M; Strassner B; Grimmer T; Peller M; Knoll A; Wagenpfeil S; Minoshima S; Schwaiger M; Kurz A
Neurology; 2005 Jan; 64(1):102-7. PubMed ID: 15642911
[TBL] [Abstract][Full Text] [Related]
10. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.
Reiman EM; Caselli RJ; Chen K; Alexander GE; Bandy D; Frost J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3334-9. PubMed ID: 11248079
[TBL] [Abstract][Full Text] [Related]
11. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
12. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8299-302. PubMed ID: 15932949
[TBL] [Abstract][Full Text] [Related]
13. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
Ichimiya A; Herholz K; Mielke R; Kessler J; Slansky I; Heiss WD
J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302
[TBL] [Abstract][Full Text] [Related]
14. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
Minthon L; Hesse C; Sjögren M; Englund E; Gustafson L; Blennow K
Neurosci Lett; 1997 Apr; 226(1):65-7. PubMed ID: 9153643
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
17. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
20. The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy.
Masullo C; Daniele A; Fazio VM; Seripa D; Gravina C; Filippini V; Grossi D; Fragassi N; Nichelli P; Leone M; Gainotti G
Neurosci Lett; 2001 May; 303(2):87-90. PubMed ID: 11311499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
